Asthmatic characteristics in smokers with advanced emphysema;Características asmáticas en pacientes fumadores con enfisema avanzado

Archivos de Bronconeumologia

Volumn 39, Issue 5, 2003, Pages 221-225

  Pacheco Galvan A ^a   Maiz L ^a   Gaudo J ^a   Pavon M J ^a   Cuevas, M ^a   Quirce, S ^b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Asthma; Atopy; Bronchial hyperresponsiveness; Emphysema; Immunoglobulin E

Indexed keywords

ALLERGEN; BRONCHODILATING AGENT; IMMUNOGLOBULIN E;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BLOOD CYTOLOGY; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EOSINOPHILIA; HUMAN; HYPOTHESIS; IMMUNOGLOBULIN BLOOD LEVEL; LUNG EMPHYSEMA; MALE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SENSITIZATION; SMOKING; SPUTUM CYTODIAGNOSIS; STATISTICAL ANALYSIS; THORAX RADIOGRAPHY;

EID: 0038274654     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13047336     Document Type: Article

References (27)

1. Burrows B. Epidemiologic evidence for different types of chronic airflow obstruction. Am Rev Respir Dis 1991;143:1452-5.
2. Weiss ST. Atopy as a risk factor for chronic obstructive pulmonary disease. Epidemiologic evidence. Am J Crit Care Med 2000; 162(Suppl):134-6.
3. O'Connor GT, Sparrow D, Weiss ST. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary function decline: the Normative Aging Study. Am J Respir Crit Care Med 1995;152:87-92.
4. Jeffery PK. Remodeling in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(Suppl):28-38.
5. Chanez P, Vignola AM, O'Shaugnessy T, Enender I, Li D, Jeffery K. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997;155:1529-34.
6. Hargreave FE, Leigh R. Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:553-7.
7. Lange P, Parner J, Vestbo J, Shnorh P, Jensen G, A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1999;339:1194-2000.
8. American Thoracic Society. ATS statement standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152(Suppl);77-121.
9. Cooper JD, Trulock EP, Triantafillou AN, Patterson GA, Pohl MS, Deloney PA, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995;109:106-19.
10. Sluiter HJ, Koeter GH, De Monchy JGR, Postma DS, DE Vries K, Orie NGM. The Dutch Hypothesis (chronic non-specific lung disease) revisited. Eur Respir J 1991;4:479-89.
11. Pacheco Galván A. Hipersensibilidad a Candida albicans en una población afecta de obstrucción crónica al flujo aéreo. Análisis mediante marcadores immunológicos específicos [tesis doctoral]. Madrid: Universidad de Alcalá, 1998.
12. American Thoracic Society. Guidelines for the evaluation of impairment/disability in patients with asthma. Am Rev Respir Dis 1993;147:1056-61.
13. Annema JT, Sparrow D, O'Connor GT, Rijcken B, Koeter GH, Postma DS, et al ST. Chronic respiratory symptoms and airway responsiveness to methacholine are associated with eosinophilia in older men; the Normative Aging Study. Eur Respir J 1995;8:62-9.
14. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edition. Hillsdale: Lawrence Earlbaum Associates, 1988.
15. Reed Ch E. The natural history of asthma in adults: the problem of irreversibility, J Allergy Clin Immunol 1999;103:539-47.
16. Balzano G, Stefanelli F, Iorio C, De Felice A, Melillo EM, Martucci M, et al. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160: 1486-92.
17. Fujimoto K, Kubo K, Yamamoto H, Yamaguchi S, Matsuzawa Y. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest 1999;115:697-702.
18. Haraguchi M, Shimura S, Shirato K. Morphologic aspects of airways of patients with pulmonary emphysema followed by bronchial asthma-like attack. Am J Respir Crit Care Med 1996;153: 638-43.
19. Nagai A, Thurlbeck WM, Cono K. Responsiveness and variability of airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:635-9.
20. Pizzichini E, Pizzichini MMM, Gibson PG, Parameswaran K, Gleich GJ, Berman L, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998;158:1511-7.
21. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax 2002; 57:178-82.
22. Brightling CE, Woltman G, Wardlaw AJ, Pavord ID. Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. Eur Respir J 1999;14:1228-30.
23. 1 in adult men. An epidemiologic longitudinal study. Chest 1992;101:642-8.
24. 1 in current asthmatic subjects. Chest 1994; 106:1089-93.
25. Apostol GC, Jacobs DR, Tsai AW, Crow RS, Williams OD, Towsend MC, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40. Am J Respir Crit Care Med 2002;166:166-72.
26. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:1802-11.
27. US Department of Health and Human Services, Public Health Service, National Heart Lung and Blood Institute. Bethesda (Maryland): Expert Panel report II: guidelines for the diagnosis and management of asthma; april 1997. NIH Publication n.° 97-4051.